Axogen Inc vs Visa Inc — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Visa Inc trades at $361.98 (market cap $671.74B). The key difference: Visa Inc is far larger — about 257.4× Axogen Inc's market cap, and Visa Inc pays a 0.74% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | V | |
|---|---|---|
Market Cap | $2.61B | $671.74B |
Sector | Technology | Financials |
52-Week High | $48.48 | $370.47 |
52-Week Low | $14.16 | $295.52 |
Enterprise Value | $2.52B | $682.32B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.74% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Visa (V) trades at $361.32, down 0.33% on the day, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q2 2026 EPS of $3.32 exceeding the $3.23 estimate. Revenue grew to $40 billion in 2025, with a net income margin of 50.78%. Recent news highlights Visa's AI initiatives, such as Intelligent Commerce Connect, to enhance payment efficiency.
The outlook remains positive due to high analyst buy ratings (85.48%) and a consensus price target of $426.31, implying 18% upside. Risks include fintech competition and regulatory pressures, but Visa's robust cash flow and profitability support long-term growth potential for investors.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →